Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin in treatment of Egyptian patients infected with chronic HCV (Single Centre Study)

ConclusionThe current study suggested that treatment of SOF plus DCV with/without RBV for chronicHCV patients in Egypt was generally safe, well tolerated, and of high efficacy, reflecting the antiviral potency and high resistance barrier of the combination regimen.
Source: QJM - Category: Internal Medicine Source Type: research